# Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

> **NCT02049034** · PHASE4 · COMPLETED · sponsor: **University of Surrey** · enrollment: 8 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** Lixisenatide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02049034
- **Lead sponsor:** University of Surrey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049034, "Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02049034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*